BUZZ-Top of the Street: Nestle, Anglo American, Bureau Veritas A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Deutsche Bank downgrades Nestle NESN.S to "hold" from "buy", saying the world's biggest packaged food company went "a cut too far" as it trimmed its sales growth outlook on Thursday ** UBS raises British miner Anglo American AAL.L to "buy" from "neutral" as it sees better risk/reward ratio after the stock fell enough following BHP's BHP.AX offer

EUROPE RESEARCH ROUNDUP-Greencore, UCB, Unilever July 26 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Greencore, UCB, and Unilever, on Friday. HIGHLIGHTS * Greencore GNC.L : HSBC raises target price to 190p from 160p * Lonza Group AG LONN.S : JP Morgan raises target price to CHF 645 from CHF 600 * Sartorius Stedim Biotech STDM.PA : HSBC cuts target price to EUR 310 from EUR 360 * UCB SA UCB.BR : TD Cowen raises target price to E

PRESS DIGEST-British Business - July 26 July 26 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Anglo American AAL.L took a $1.6 billion writedown at its Woodsmith mine fertiliser project in Britain. - Britain’s accounting watchdog, the Financial Reporting Council, issued financial sanctions totalling 48.2 million pounds ($61.98 million) in the year to the end of

BREAKINGVIEWS-Anglo American has a job to exit post-BHP hole The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Karen Kwok LONDON, July 25 (Reuters Breakingviews) - Duncan Wanblad’s job is not getting any easier. Two months after fending off Australian rival BHP’s BHP.AX $47 billion approach, the Anglo American AAL.L boss on Thursday delivered a decent set of half-year results.

UPDATE 1-UK Stocks-Factors to watch on July 25 Adds new items, updates futures July 25 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening lower on Thursday, with futures FFIc1 down 0.6%. * ASTRAZENECA: Anglo-Swedish drugmaker AstraZeneca AZN.L raised its sales and profit forecasts for 2024 and topped analyst expectations for second-quarter revenue, buoyed by demand for its therapies for cancer and rare diseases.